COX-2 as a novel target of CRF family peptides' participating in inflammation

Biochemical and Biophysical Research Communications

Volumn 382, Issue 3, 2009, Pages 483-485

  Zhang, Rongjian ^a   Li, Shengnan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Corticotropin releasing factor; Corticotropin releasing factor receptor; Cyclooxygenase 2; Inflammation; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLOOXYGENASE 2; PEPTIDE; UROCORTIN I; UROCORTIN II; UROCORTIN III;

AUTOCRINE EFFECT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; CYCLOOXYGENASE 2; HUMANS; INFLAMMATION;

MAMMALIA;

EID: 64049098301     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.064     Document Type: Short Survey

References (40)

1. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic-peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
2. Bale T.L., and Vale W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 525-557
3. Fekete E.M., and Zorrilla E.P. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front. Neuroendocrinol. 28 (2007) 1-27
4. Kohno M., Kawahito Y., Tsubouchi Y., Hashiramoto A., Yamada R., Inoue K.I., Kusaka Y., Kubo T., Elenkov I.J., Chrousos G.P., Kondo M., and Sano H. Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J. Clin. Endocrinol. Metab. 86 (2001) 4344-4352
5. Saruta M., Takahashi K., Suzuki T., Torii A., Kawakami M., and Sasano H. Urocortin 1 in colonic mucosa in patients with ulcerative colitis. J. Clin. Endocrinol. Metab. 89 (2004) 5352-5361
6. Theoharides T.C., Donelan J.M., Papadopoulou N., Cao J., Kempuraj D., and Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci. 25 (2004) 563-568
7. Wu Y., Zhou H., Xu Y., and Li S. Enhanced expression of urocortin in lung tissues of rats with allergic asthma. Biochem. Biophys. Res. Commun. 341 (2006) 532-540
8. Wu Y., Xu Y., Zhou H., Tao J., and Li S. Expression of urocortin in rat lung and its effect on pulmonary vascular permeability. J. Endocrinol. 189 (2006) 167-178
9. Wu Y., Hu J., Zhang R., Zhou C., Xu Y., Guan X., and Li S. Enhanced intracellular calcium induced by urocortin is involved in degranulation of rat lung mast cells. Cell. Physiol. Biochem. 21 (2008) 173-182
10. Y. Wu, R. Zhang, C. Zhou, Y. Xu, X. Guan, J. Hu, Y. Xu, S. Li, Enhanced expression of vascular cell adhesion molecule-1 by corticotrophin-releasing hormone contributes to progression of atherosclerosis in LDL receptor-deficient mice, Atherosclerosis, doi:10.1016/j.atherosclerosis.2008.05.059.
11. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12 (1998) 1063-1073
12. Anderson G.D., Hauser S.D., McGarity K.L., Bremer M.E., Isakson P.C., and Gregory S.A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97 (1996) 2672-2679
13. McEvoy A.N., Bresnihan B., FitzGerald O., and Murphy E.P. Cyclooxygenase 2-derived prostaglandin E2 production by corticotropin-releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissue. Arthritis Rheum. 50 (2004) 1132-1145
14. Tsatsanis C., Androulidaki A., Dermitzaki E., Gravanis A., and Margioris A.N. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. J. Cell. Physiol. 210 (2007) 774-783
15. Kageyama K., Hanada K., Nigawara T., Moriyama T., Terui K., Sakihara S., and Suda T. Urocortin induces interleukin-6 gene expression via cyclooxygenase-2 activity in aortic smooth muscle cells. Endocrinology 147 (2006) 4454-4462
16. McEvoy A.N., Bresnihan B., Fitzgerald O., and Murphy E.P. Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway. Ann. NY Acad. Sci. 966 (2002) 119-130
17. Siegle I., Klein T., Backman J.T., Saal J.G., Nüsing R.M., and Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum. 41 (1998) 122-129
18. Puéchal X., and Fiessinger J.N. Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist. Rheumatology 46 (2007) 192-199
19. Agelaki S., Tsatsanis C., Gravanis A., and Margioris A.N. Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect. Immun. 70 (2002) 6068-6074
20. Tsatsanis C., Androulidaki A., Dermitzaki E., Charalampopoulos I., Spiess J., Gravanis A., and Margioris A.N. Urocortin 1 and urocortin 2 induce macrophage apoptosis via CRFR2. FEBS Lett. 579 (2005) 4259-4264
21. Tsatsanis C., Androulidaki A., Alissafi T., Charalampopoulos I., Dermitzaki E., Roger T., Gravanis A., and Margioris A.N. Corticotropin-releasing factor the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J. Immunol. 176 (2006) 1869-1877
22. Alvi S.A., Brown N.L., Bennett P.R., Elder M.G., and Sullivan M.H. Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. Mol. Hum. Reprod. 5 (1999) 476-480
23. Gao L., Lu C., Xu C., Tao Y., Cong B., and Ni X. Differential regulation of prostaglandin production mediated by corticotropin-releasing hormone receptor type 1 and type 2 in cultured human placental trophoblasts. Endocrinology 149 (2008) 2866-2876
24. Karteris E., Grammatopoulos D., Dai Y., Olah K.B., Ghobara T.B., Easton A., and Hillhouse E.W. The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1alpha (CRH-1alpha) and the CRH-C variant receptor. J. Clin. Endocrinol. Metab. 83 (1998) 1376-1379
25. Markovic D., Punn A., Lehnert H., and Grammatopoulos D.K. Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol. Endocrinol. 22 (2008) 689-706
26. Punn A., Levine M.A., and Grammatopoulos D.K. Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation. Mol. Endocrinol. 20 (2006) 3179-3195
27. Hoare S.R., Sullivan S.K., Fan J., Khongsaly K., and Grigoriadis D.E. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity. Peptides 26 (2005) 457-470
28. Dermitzaki E., Tsatsanis C., Gravanis A., and Margioris A.N. Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase. J. Biol. Chem. 277 (2002) 12280-12287
29. Grammatopoulos D.K., Randeva H.S., Levine M.A., Katsanou E.S., and Hillhouse E.W. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Mol. Endocrinol. 14 (2000) 2076-2091
30. Slominski A., Zbytek B., Zmijewski M., Slominski R.M., Kauser S., Wortsman J., and Tobin D.J. Corticotropin releasing hormone and the skin. Front. Biosci. 11 (2006) 2230-2248
31. Wang M.J., Lin S.Z., Kuo J.S., Huang H.Y., Tzeng S.F., Liao C.H., Chen D.C., and Chen W.F. Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J. Immunol. 179 (2007) 6204-6214
32. Caivano M., and Cohen P. Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages. J. Immunol. 164 (2000) 3018-3025
33. Wu M.H., Wang C.A., Lin C.C., Chen L.C., Chang W.C., and Tsai S.J. Distinct regulation of cyclooxygenase-2 by interleukin-1beta in normal and endometriotic stromal cells. J. Clin. Endocrinol. Metab. 90 (2005) 286-295
34. Chun K.S., and Surh Y.J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68 (2004) 1089-1100
35. Tsatsanis C., Androulidaki A., Venihaki M., and Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell. Biol. 38 (2006) 1654-1661
36. Eliopoulos A.G., Dumitru C.D., Wang C.C., Cho J., and Tsichlis P.N. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 21 (2002) 4831-4840
37. Chen C.C. Signal transduction pathways of inflammatory gene expressions and therapeutic implications. Curr. Pharm. Des. 12 (2006) 3497-3508
38. Moss A.C., Anton P., Savidge T., Newman P., Cheifetz A.S., Gay J., Paraschos S., Winter M.W., Moyer M.P., Karalis K., Kokkotou E., and Pothoulakis C. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha. Gut 56 (2007) 1210-1217
39. Murphy E.P., and Conneely O.M. Neuroendocrine regulation of the hypothalamic-pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol. Endocrinol. 11 (1997) 39-47
40. Rossant C.J., Pinnock R.D., Hughes J., Hall M.D., and McNulty S. Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3′,5′-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase. Endocrinology 140 (1999) 1525-1536